Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J1CC
|
||||
| Former ID |
DIB019397
|
||||
| Drug Name |
compound 28
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H15BrF2N4O2S3
|
||||
| InChI |
InChI=1S/C20H15BrF2N4O2S3/c1-30-20-17(7-16(31-20)19(24)25)32(28,29)12-5-13(21)18-15(6-12)26-9-27(18)8-10-4-11(22)2-3-14(10)23/h2-7,9H,8H2,1H3,(H3,24,25)
|
||||
| InChIKey |
HEZXZGJJNMPIJM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | C1 esterase | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| Pertussis | |||||
| Staphylococcus aureus infection | |||||
| Systemic lupus erythematosus | |||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Complement Activation, Classical Pathway | |||||
| Human Complement System | |||||
| Complement cascade | |||||
| References | |||||
| REF 1 | A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2200-4. Epub 2006 Feb 3. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.